Vivos Therapeutics Earnings Estimate

VVOS Stock

USD 2.95 0.06 2.08%

By analyzing Vivos Therapeutics' earnings estimates, investors can diagnose different trends across Vivos Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Vivos Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.

Covid

Vivos Therapeutics is projected to generate -0.4475 in earnings per share on the 31st of December 2024. Vivos Therapeutics earnings estimates module stress-tests analyst consensus about projected Vivos Therapeutics EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Vivos Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Vivos Therapeutics Revenue Breakdown by Earning Segment

By analyzing Vivos Therapeutics' earnings estimates, investors can diagnose different trends across Vivos Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Vivos Therapeutics' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.78 in 2024, whereas Pretax Profit Margin is likely to drop (1.03) in 2024.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivos Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

Vivos Therapeutics Earnings per Share Projection vs Actual

About Vivos Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Vivos Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Vivos Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Vivos Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'

Please read more on our stock advisor page.

	Last Reported	Projected for Next Year
Retained Earnings	-93.1 M	-88.4 M
Earnings Yield	(0.90)	(0.94)
Price Earnings Ratio	(1.12)	(1.17)
Price Earnings To Growth Ratio	0.02	0.02

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC